Education & Training
- BA, University of Pennsylvania, Philadelphia PA
- MD, Vanderbilt University School of Medicine, Nashville, TN
- Residency, Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA
- Fellowship, Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA
Representative Publications
Orellana TJ, Kim H, Beriwal S, Taylor SE, Smith KJ, Lesnock JL. Cost-effectiveness analysis of tumor molecular testing in stage III endometrial cancer. Gynecol Oncol, 2023 Jun; 173:81-87. Doi: 10.1016/j.ygyno.2023.04.010. PMID: 37105061
Bell S, Orellana T, Garrett A, Smith K, Kim H, Rosiello A, Rush S, Berger J, Lesnock J. Prophylactic anticoagulation after minimally invasive hysterectomy for endometrial cancer: a cost-effectiveness analysis. Int J Gynecol Cancer. 2023 Dec 4;33(12):1875-1881. doi: 10.1136/ijgc-2023-004922 .PMID: 37903564
MaCarthy EC, Radolec M, Rinda Soong T, Elishaev E, Buckanovich R, Taylor SE, Lesnock J. Clinical outcomes following identification of an incidental p53 signature in the fallopian tube. Gynecol Oncol Rep. 2024 Mar 5;52:101359. doi: 10.1016/j.gore.2024.101359. eCollection 2024 Apr.PMID: 38495800
Ertel M, Vargo JA, Weimer A, Richman A, Beriwal S, Mohammed M, Lesnock J.
Surgical Margins After Neoadjuvant Radiation for Locally Advanced Vulvar Carcinoma: What is an Adequate Margin? Am J Clin Oncol. 2024 Jul 8. doi: 10.1097/COC.0000000000001127. PMID: 38973252
Gaillard S, Lacchetti C, Armstrong DK, Cliby WA, Edelson MI, Garcia AA, Ghebre RG, Gressel GM, Lesnock JL, Meyer LA, Moore KN, O’Cearbhaill RE, Olawaiye AB, Salani R, Sparacio D, van Driel J, Tew WP. Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update. J Clin Oncol 2025 Mar;43(7): 868-891. Doi: 10.1200/JCO-24-02589. Epub 2025 Jan 22. PMID: 39841949
Clinical Interests/Research Interests
I have an interest in cost-effectiveness analyses across the spectrum of gynecologic oncology, as well as evaluating clinical outcomes via institutional or large database sets to answer questions not readily evaluable with prospective trials and translational research.